Search

Your search keyword '"E. Agabiti Rosei"' showing total 606 results

Search Constraints

Start Over You searched for: Author "E. Agabiti Rosei" Remove constraint Author: "E. Agabiti Rosei"
606 results on '"E. Agabiti Rosei"'

Search Results

1. P141 COMPARISON BETWEEN TECHNIQUES OF EVALUATION MICROVASCULAR MORPHOLOGY: THE GOLD-STANDARD LOCALLY INVASIVE MICROMYOGRAPHY VS. THREE NON-INVASIVE TECHNIQUES. PRELIMINARY DATA

2. 5.7 SUBPOPULATIONS OF CIRCULATING T LYMPHOCYTES IN OBESE PATIENTS UNDERGOING BARIATRIC SURGERY

3. P6.18 CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS; ARE THERE ANY DIFFERENCES?

4. P3.29 ASSESSMENT OF THE DETERMINANTS OF LOCAL CAROTID STIFFNESS IN A GENERAL POPULATION IN NORTHERN ITALY

5. 5.6 LONG-TERM TREATMENT WITH MELATONIN MAI IMPROVE ANTICONTRACTILE ACTIVITY OF PERIVASCULAR FAT IN OBESE MICE

6. P3.06 ASSESSMENT OF ARTERIAL STIFFNESS DURING A FIVE-YEARS FOLLOW UP IN A GENERAL POPULATION IN NORTHERN ITALY

7. P1.16 CORRELATION BETWEEN WALL-TO-LUMEN RATIO OF RETINAL ARTERIOLES AND CLINIC AND 24 HOURS BLOOD PRESSURE

8. 3.5 EFFECT OF SHORT-TERM TREATMENT WITH LERCANIDIPINE ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND STRUCTURAL ALTERATIONS IN RETINAL ARTERIOLES

11. P2.01 RELATIONSHIP BETWEEN MEDIA TO LUMEN RATIO OF SUBCUTANEOUS SMALL ARTERIES AND WALL TO LUMEN RATIO OF RETINAL ARTERIOLES EVALUATED NON INVASIVELY BY SCANNING LASER DOPPLER FLOWMETRY

18. 8.4 ARTERIAL COMPLIANCE AND CAROTID ATHEROSCLEROSIS IN APOLIPOPROTEIN A-I AMYLOIDOSIS (LEU75PRO)

20. P5460Prevalence of left atrial enlargement in patients undergoing an echocardiogram for cardiovascular risk stratification at an esh excellence centre in italy

21. Microvascular Alterations in Obesity

22. PREVALENCE OF LEFT ATRIAL ENLARGEMENT IN A LARGE SAMPLE OF PATIENTS UNDERGOING AN ECHOCARDIOGRAM FOR CARDIOVASCULAR RISK STRATIFICATION AT AN ESH EXCELLENCE CENTRE IN ITALY

23. Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function

24. ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE ESH-FA PROJECT- DATA ON CROATIAN COHORT

25. RELATIONSHIP BETWEEN UNATTENDED AND ATTENDED BP VALUES AND ARTERIAL STIFFNESS DAMAGE

26. Beyond gout: uric acid and cardiovascular diseases

27. Poster session Friday 7 December - PM: Effect of systemic illnesses on the heart

28. [BP.03.03] CARDIOVASCULAR RISK AND HYPERTENSION CONTROL IN ITALY. DATA FROM THE 2015 WORLD HYPERTENSION DAY

29. [PP.09.17] REPRODUCIBILITY OF THE EVALUATION OF THE WALL TO LUMEN RATIO OF RETINAL ARTERIOLES WITH TWO DIFFERENT NON-INVASIVE APPROACHES

30. [OP.7C.04] ARTERIAL STIFFNESS IS INDEPENDENTLY CORRELATED WITH MYOCARDIAL MECHANOENERGETIC EFFICIENCY IN A GENERAL POPULATION IN NORTHERN ITALY

31. Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized 'Z' Studies

32. RELATIONSHIP BETWEEN UNATTENDED AND ATTENDED BP VALUES AND PRECLINICAL ORGAN DAMAGE

33. ASSESSEMENT OF MYOCARDIAL MECHANOENERGETIC EFFICIENCY IN PATIENTS WITH PRIMARY ALDOSTERONISM

34. UNATTENDED VS ATTENDED BP MEASUREMENT

35. CHARACTERISTICS OF PATIENTS WITH ATRIAL FIBRILLATION. ESH-FA PROJECT – DATA ON CROATIAN COHORT

36. Small artery remodeling in diabetes mellitus

37. Fine needle cytology of complex thyroid nodules

39. Inverse Relation between Serum Adiponectin and Left Ventricular Mass in Hypertensive Women

40. Role of β-Adrenergic Receptors on Nitric Oxide-Dependent Tissue-Type Plasminogen Activator (t-PA) Release in Normotensive Subjects and Hypertensive Patients

41. Patients with Essential Hypertension Show the Presence of an Altered Structure of Small Cerebral Arteries

42. Soluble Cell Adhesion Molecules in Never Treated Essential Hypertensives: Relationship with Vascular Structural Changes

43. Left Ventricular Mass Appropriateness in Patients with Primary Aldosteronism

44. Impaired Insulin Signalling in Lympho/Monocytes of Patients with Metabolic Syndrome

45. Impaired Insulin Signalling in the Heart and Skeletal Muscle of Spontaneously Hypertensive Rats, and Effects of Treatment with an Angiotensin Receptor Blocker or with an ACE Inhibitor

46. A Peculiar Case of Secondary Hypertension

47. Vascular Remodelling and Duration of Hypertension Predicts Blood Pressure Response to Adrenalectomy in Aldosterone-Producing Adenoma Patients

48. P6.18 CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS; ARE THERE ANY DIFFERENCES?

50. Adalimumab for Rheumatoid Arthritis

Catalog

Books, media, physical & digital resources